Michelle Bolduc
Family Medicine · Portsmouth, NHNPI 1164005302
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,337 and has fallen 97.7% since, to $30 in 2025. Among family medicine clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$515
- AbbVie$393
- Boehringer Ingelheim$304
- Takeda Pharmaceuticals U.S.A., Inc.$128
- Johnson & Johnson$110
- GSK$107
- plus $872 from 16 others
What the payments were for
- Food & beverage$2,429100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $515 |
| AbbVie(2 entities) | 25 | $393 |
| Boehringer Ingelheim | 17 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
| Johnson & Johnson | 6 | $110 |
| GSK | 5 | $107 |
| Amarin Pharma, Inc. | 5 | $104 |
| Pfizer | 6 | $104 |
| Lilly USA, LLC | 6 | $97 |
| Novo Nordisk | 5 | $90 |
| Merck | 5 | $87 |
| Revance Therapeutics, Inc. | 2 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $68 |
| Novartis | 4 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Biodelivery Sciences International, Inc. | 1 | $24 |
| Bayer | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
How this compares
$2,429 in reported general payments places this provider in the 90th percentile of 397 family medicine providers in New Hampshire.
Other family medicine in Portsmouth
- Mark BallentynePortsmouth$135K
- M LauterPortsmouth$21K
- Keenan Al-HojerryPortsmouth$11K
- Brian SponsellerNorth Conway$15K
- Cecilia Vicuna KeadyCharlestown$13K
- Peter LoeserConcord$10K
- Robyn StewartDerry$8K
- Robert KellyExeter$8K
- Dennis BadmanSanbornville$7K
- Ajay KoshyBedford$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.